Management of brainstem cavernous malformations

Tarek Y. El Ahmadieh, Salah G. Aoun, Bernard R. Bendok, H. Hunt Batjer

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The risk of hemorrhage from brainstem cavernous malformations (BSCMs) ranges between 2.33 % and 4.1 % per patient-year across natural history studies and between 2.68 % and 6.8 % per patient-year across surgical series. The recurrent hemorrhage rate from BSCMs ranges between 5 % and 60 % per patient-year. Asymptomatic BSCMs tend to have a benign course, whereas symptomatic lesions often have a more aggressive course and carry an increasing risk of hemorrhage with subsequent bleeds. Hemorrhagic presentation, female gender, family history, and associating venous anomalies have been correlated with an increased risk of hemorrhage from BSCMs. MRI is the diagnostic imaging method of choice for the detection of CMs. Preoperative T1-weighted MRI can help assess the proximity of the lesion to the pial or ependymal surface of the brainstem and is thus essential to operative planning. Fluid attenuated inversion recovery (FLAIR) sequences can detect inflammatory activity and perilesional gliosis and may therefore correlate with an increased biological activity in the CM. This might help predict the aggressiveness of these lesions and their clinical activity. Due to the potential risks of surgery, conservative management with close follow-up should be the primary treatment option for patients with BSCMs. At least two clinically significant hemorrhagic episodes and an anatomical pial representation of the lesion are required before considering surgical intervention as an option because of the potential irreversible neurological damage to the patient. Life-threatening bleeds and rapidly progressive neurological deterioration are also potential indications for surgery. Complete removal of BSCMs when feasible is crucial to the prevention of future hemorrhage from BSCMs. An intraoperative ultrasound and a post-operative MRI can be used to rule out any unnoticed residual lesion. Minimizing the risk of surgery can be achieved by undergoing a case-based selection of the optimal surgical approach that allows for easy access to the lesion with minimal manipulation of normal neural tissues. Preserving any associated venous anomaly during surgery is crucial in order to avoid any undesirable hemorrhagic infarction. Advanced imaging techniques, such as diffusion tensor imaging integrated with intra-operative neuronavigation MRI, can be used to determine the anatomical relation between BSCM and the surrounding eloquent structures. Radiosurgery is not considered an effective treatment option for BSCMs. It is reserved only for extremely biologically aggressive lesions that cannot be accessed surgically.

Original languageEnglish (US)
Pages (from-to)237-251
Number of pages15
JournalCurrent Treatment Options in Cardiovascular Medicine
Volume14
Issue number3
DOIs
StatePublished - 2012

Fingerprint

Brain Stem
Hemorrhage
Neuronavigation
Sequence Inversion
Diffusion Tensor Imaging
Gliosis
Radiosurgery
Diagnostic Imaging
Natural History
Infarction
Therapeutics

Keywords

  • Brainstem
  • Brainstem cavernous malformations
  • BSCM
  • Cavernous malformations
  • Diffusion tensor imaging
  • Hemorrhage rate
  • Indications
  • Natural history
  • Outcomes
  • Radiosurgery
  • Re-hemorrhage rate
  • Risk factors
  • Surgery
  • Surgical approach

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Management of brainstem cavernous malformations. / El Ahmadieh, Tarek Y.; Aoun, Salah G.; Bendok, Bernard R.; Batjer, H. Hunt.

In: Current Treatment Options in Cardiovascular Medicine, Vol. 14, No. 3, 2012, p. 237-251.

Research output: Contribution to journalArticle

El Ahmadieh, Tarek Y. ; Aoun, Salah G. ; Bendok, Bernard R. ; Batjer, H. Hunt. / Management of brainstem cavernous malformations. In: Current Treatment Options in Cardiovascular Medicine. 2012 ; Vol. 14, No. 3. pp. 237-251.
@article{81774df522e34dc69db23c8b6f9d2608,
title = "Management of brainstem cavernous malformations",
abstract = "The risk of hemorrhage from brainstem cavernous malformations (BSCMs) ranges between 2.33 {\%} and 4.1 {\%} per patient-year across natural history studies and between 2.68 {\%} and 6.8 {\%} per patient-year across surgical series. The recurrent hemorrhage rate from BSCMs ranges between 5 {\%} and 60 {\%} per patient-year. Asymptomatic BSCMs tend to have a benign course, whereas symptomatic lesions often have a more aggressive course and carry an increasing risk of hemorrhage with subsequent bleeds. Hemorrhagic presentation, female gender, family history, and associating venous anomalies have been correlated with an increased risk of hemorrhage from BSCMs. MRI is the diagnostic imaging method of choice for the detection of CMs. Preoperative T1-weighted MRI can help assess the proximity of the lesion to the pial or ependymal surface of the brainstem and is thus essential to operative planning. Fluid attenuated inversion recovery (FLAIR) sequences can detect inflammatory activity and perilesional gliosis and may therefore correlate with an increased biological activity in the CM. This might help predict the aggressiveness of these lesions and their clinical activity. Due to the potential risks of surgery, conservative management with close follow-up should be the primary treatment option for patients with BSCMs. At least two clinically significant hemorrhagic episodes and an anatomical pial representation of the lesion are required before considering surgical intervention as an option because of the potential irreversible neurological damage to the patient. Life-threatening bleeds and rapidly progressive neurological deterioration are also potential indications for surgery. Complete removal of BSCMs when feasible is crucial to the prevention of future hemorrhage from BSCMs. An intraoperative ultrasound and a post-operative MRI can be used to rule out any unnoticed residual lesion. Minimizing the risk of surgery can be achieved by undergoing a case-based selection of the optimal surgical approach that allows for easy access to the lesion with minimal manipulation of normal neural tissues. Preserving any associated venous anomaly during surgery is crucial in order to avoid any undesirable hemorrhagic infarction. Advanced imaging techniques, such as diffusion tensor imaging integrated with intra-operative neuronavigation MRI, can be used to determine the anatomical relation between BSCM and the surrounding eloquent structures. Radiosurgery is not considered an effective treatment option for BSCMs. It is reserved only for extremely biologically aggressive lesions that cannot be accessed surgically.",
keywords = "Brainstem, Brainstem cavernous malformations, BSCM, Cavernous malformations, Diffusion tensor imaging, Hemorrhage rate, Indications, Natural history, Outcomes, Radiosurgery, Re-hemorrhage rate, Risk factors, Surgery, Surgical approach",
author = "{El Ahmadieh}, {Tarek Y.} and Aoun, {Salah G.} and Bendok, {Bernard R.} and Batjer, {H. Hunt}",
year = "2012",
doi = "10.1007/s11936-012-0181-x",
language = "English (US)",
volume = "14",
pages = "237--251",
journal = "Current Treatment Options in Cardiovascular Medicine",
issn = "1092-8464",
publisher = "Current Science, Inc.",
number = "3",

}

TY - JOUR

T1 - Management of brainstem cavernous malformations

AU - El Ahmadieh, Tarek Y.

AU - Aoun, Salah G.

AU - Bendok, Bernard R.

AU - Batjer, H. Hunt

PY - 2012

Y1 - 2012

N2 - The risk of hemorrhage from brainstem cavernous malformations (BSCMs) ranges between 2.33 % and 4.1 % per patient-year across natural history studies and between 2.68 % and 6.8 % per patient-year across surgical series. The recurrent hemorrhage rate from BSCMs ranges between 5 % and 60 % per patient-year. Asymptomatic BSCMs tend to have a benign course, whereas symptomatic lesions often have a more aggressive course and carry an increasing risk of hemorrhage with subsequent bleeds. Hemorrhagic presentation, female gender, family history, and associating venous anomalies have been correlated with an increased risk of hemorrhage from BSCMs. MRI is the diagnostic imaging method of choice for the detection of CMs. Preoperative T1-weighted MRI can help assess the proximity of the lesion to the pial or ependymal surface of the brainstem and is thus essential to operative planning. Fluid attenuated inversion recovery (FLAIR) sequences can detect inflammatory activity and perilesional gliosis and may therefore correlate with an increased biological activity in the CM. This might help predict the aggressiveness of these lesions and their clinical activity. Due to the potential risks of surgery, conservative management with close follow-up should be the primary treatment option for patients with BSCMs. At least two clinically significant hemorrhagic episodes and an anatomical pial representation of the lesion are required before considering surgical intervention as an option because of the potential irreversible neurological damage to the patient. Life-threatening bleeds and rapidly progressive neurological deterioration are also potential indications for surgery. Complete removal of BSCMs when feasible is crucial to the prevention of future hemorrhage from BSCMs. An intraoperative ultrasound and a post-operative MRI can be used to rule out any unnoticed residual lesion. Minimizing the risk of surgery can be achieved by undergoing a case-based selection of the optimal surgical approach that allows for easy access to the lesion with minimal manipulation of normal neural tissues. Preserving any associated venous anomaly during surgery is crucial in order to avoid any undesirable hemorrhagic infarction. Advanced imaging techniques, such as diffusion tensor imaging integrated with intra-operative neuronavigation MRI, can be used to determine the anatomical relation between BSCM and the surrounding eloquent structures. Radiosurgery is not considered an effective treatment option for BSCMs. It is reserved only for extremely biologically aggressive lesions that cannot be accessed surgically.

AB - The risk of hemorrhage from brainstem cavernous malformations (BSCMs) ranges between 2.33 % and 4.1 % per patient-year across natural history studies and between 2.68 % and 6.8 % per patient-year across surgical series. The recurrent hemorrhage rate from BSCMs ranges between 5 % and 60 % per patient-year. Asymptomatic BSCMs tend to have a benign course, whereas symptomatic lesions often have a more aggressive course and carry an increasing risk of hemorrhage with subsequent bleeds. Hemorrhagic presentation, female gender, family history, and associating venous anomalies have been correlated with an increased risk of hemorrhage from BSCMs. MRI is the diagnostic imaging method of choice for the detection of CMs. Preoperative T1-weighted MRI can help assess the proximity of the lesion to the pial or ependymal surface of the brainstem and is thus essential to operative planning. Fluid attenuated inversion recovery (FLAIR) sequences can detect inflammatory activity and perilesional gliosis and may therefore correlate with an increased biological activity in the CM. This might help predict the aggressiveness of these lesions and their clinical activity. Due to the potential risks of surgery, conservative management with close follow-up should be the primary treatment option for patients with BSCMs. At least two clinically significant hemorrhagic episodes and an anatomical pial representation of the lesion are required before considering surgical intervention as an option because of the potential irreversible neurological damage to the patient. Life-threatening bleeds and rapidly progressive neurological deterioration are also potential indications for surgery. Complete removal of BSCMs when feasible is crucial to the prevention of future hemorrhage from BSCMs. An intraoperative ultrasound and a post-operative MRI can be used to rule out any unnoticed residual lesion. Minimizing the risk of surgery can be achieved by undergoing a case-based selection of the optimal surgical approach that allows for easy access to the lesion with minimal manipulation of normal neural tissues. Preserving any associated venous anomaly during surgery is crucial in order to avoid any undesirable hemorrhagic infarction. Advanced imaging techniques, such as diffusion tensor imaging integrated with intra-operative neuronavigation MRI, can be used to determine the anatomical relation between BSCM and the surrounding eloquent structures. Radiosurgery is not considered an effective treatment option for BSCMs. It is reserved only for extremely biologically aggressive lesions that cannot be accessed surgically.

KW - Brainstem

KW - Brainstem cavernous malformations

KW - BSCM

KW - Cavernous malformations

KW - Diffusion tensor imaging

KW - Hemorrhage rate

KW - Indications

KW - Natural history

KW - Outcomes

KW - Radiosurgery

KW - Re-hemorrhage rate

KW - Risk factors

KW - Surgery

KW - Surgical approach

UR - http://www.scopus.com/inward/record.url?scp=84865701143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865701143&partnerID=8YFLogxK

U2 - 10.1007/s11936-012-0181-x

DO - 10.1007/s11936-012-0181-x

M3 - Article

C2 - 22555447

AN - SCOPUS:84865701143

VL - 14

SP - 237

EP - 251

JO - Current Treatment Options in Cardiovascular Medicine

JF - Current Treatment Options in Cardiovascular Medicine

SN - 1092-8464

IS - 3

ER -